Found 8 matching trials
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL N/A This is a prospective, observational, multicenter, cohort study with 400 ne...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Learn More & Join Trial
Neurocognitive Assessment in Long-Term Survivors of Lymphoma N/A This is an observational, multicenter, prospective cohort study including p...
Show More Location
Clinica di Ematologia, AOU Ospedali Riuniti
Learn More & Join Trial
Mirror Therapy and Augmented Reality in Stroke Rehabilitation NA This research is in line with the National Health Research Institutes (NHRI...
Show More Location
Taipei Hospital, Ministry of Health and Welfare
Learn More & Join Trial
Linperlisib Combined With Chidamide in Patients With PTCL PHASE1 The phase Ib part of this study aims to determine the recommended phase II ...
Show More Location
Affiliated Cancer Hospital of Zhengzhou University
Learn More & Join Trial
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) PHASE1 This is a phase 1/2 open-label study to evaluate GW5282 in combination with...
Show More Location
Chongqing Cancer Hospital
Learn More & Join Trial
The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma. PHASE2 This is a prospective, single-center, open-label clinical study designed to...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma PHASE2 This prospective,multi-center,open-label, controlled study will evaluate th...
Show More Location
Department of Hematology, Peking University Third Hospital, Beijing, China
Learn More & Join Trial